- Exchange: London
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
AstraZeneca PLC
+ Add to WatchlistAZN:LN
3,428.000 GBp 1.500 0.04%As of 11:35:16 ET on 05/24/2013.
Snapshot for AstraZeneca PLC (AZN)
| Open: | 3,436.500 | Day's Range: | 3,409.500 - 3,444.500 | Volume: | 1,228,567 |
|---|---|---|---|---|---|
| Previous Close: | 3,428.000 | 52wk Range: | 2,578.500 - 3,487.500 | 1-Yr Rtn: | +38.25% |
Key Statistics for AZN
| Current P/E Ratio (ttm) | 11.4688 |
|---|---|
| Estimated P/E(12/2013) | 9.6059 |
| Relative P/E vs. UKX | 0.6889 |
| Earnings Per Share (USD) (ttm) | 4.5223 |
| Est. EPS (USD) (12/2013) | 5.3940 |
| Est. PEG Ratio | - |
| Market Cap (M GBP) | 42,897.59 |
| Shares Outstanding (M) | 1,251.39 |
| 30 Day Average Volume | 1,993,771 |
| Price/Book (mrq) | 2.9076 |
| Price/Sale (ttm) | 2.4054 |
| Dividend Indicated Gross Yield | 5.82% |
| Cash Dividend (USD) | 1.9000 |
| Last Dividend | 02/13/2013 |
| 5 Year Dividend Growth | 13.74% |
| Next Earnings Announcement | 08/01/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AZN
Company Profile & Key Executives for AZN
AstraZeneca PLC is a holding company. The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia, and Infection.
| Pascal SoriotChief Executive Officer | Simon Jonathan LowthChief Financial Officer |
| Katarina AgeborgChief Compliance Officer | Ruud DobberExec VP:Europe |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AZN News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page